Sign in

CIK 0001420720

  • Non-accelerated filer
  • Smaller reporting company
Ticker
IBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
262797813
Phone
+1 302-355-0650
Business address
600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
Former names
iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-08-07 Eastern Capital LTD 10% owner Sale −1,355,604 $3.83 $5.2M 31,758,993
2020-08-07 Eastern Capital LTD 10% owner Conversion · Series B Preferred Stock −5,785 0
2020-08-06 Eastern Capital LTD 10% owner Sale −2,768,137 $4.18 $11.6M 33,114,597
2020-08-05 Eastern Capital LTD 10% owner Sale −900,000 $4.46 $4.0M 35,882,734
2020-08-04 Eastern Capital LTD 10% owner Sale −600,000 $4.39 $2.6M 36,782,734
2020-06-12 Kay Robert Director Grant or award · Stock Option +400,000 400,000
2020-06-12 Kay Robert Director Grant or award · Stock Option +400,000 400,000
2020-06-04 ERWIN ROBERT L President Option exercise +28,268 $0.93 $26K 108,108
2020-06-04 ERWIN ROBERT L President Sale −28,268 $1.71 $48K 108,108
2020-06-04 ERWIN ROBERT L President Option exercise · Stock Option (right to buy) −28,268 108,108
2020-06-02 ERWIN ROBERT L President Option exercise +96,124 $0.93 $89K 136,376
2020-06-02 ERWIN ROBERT L President Sale −96,124 $1.62 $156K 136,376
2020-06-02 ERWIN ROBERT L President Option exercise · Stock Option (right to buy) −96,124 136,376
2020-05-27 Mullaney James P. Chief Financial Officer Option exercise +11,250 $0.93 $10K 0
2020-05-27 Mullaney James P. Chief Financial Officer Sale −11,250 $1.61 $18K 0
2020-05-27 Mullaney James P. Chief Financial Officer Option exercise · Stock Option (right to buy) −11,250 0
2020-04-21 Isett Thomas Francis 3rd CEO and Executive Chairman Grant or award · Stock Option (right to buy) +975,000 $0.90 $873K 1,275,000
2020-03-19 Isett Thomas Francis 3rd CEO and Executive Co-Chairman Conversion +100,000 $0.20 $20K 1,275,000
2020-03-19 Isett Thomas Francis 3rd CEO and Executive Co-Chairman Conversion · Series C Convertible Preferred Stock +20 $1,000.00 $20K 1,275,000
2020-03-17 Isett Thomas Francis 3rd CEO and Executive Co-Chairman Option exercise +78,024 $0.22 $17K 1,275,000

Page 6 of 7 · 126 trades